Lies Vanneste

Lies Vanneste is an experienced professional in investor relations and operational management, currently serving as Director of Investor Relations at Sequana Medical NV since July 2018. Previously, Lies held the same title at Ablynx from October 2010 to June 2018, where responsibilities included implementing international communication strategies and managing media relations. Lies has also worked as a Senior Business Analyst and Project Planner at Ablynx, focusing on commercial opportunity assessments and operational planning. Prior experience includes Head of Discovery Operations at Pronota, Drug Safety Associate at Covance, and Research Associate at Innogenetics, with a strong background in project management, quality management, and regulatory affairs. Lies holds a Master’s degree in Biochemistry from University College Ostend, which is now part of KU Leuven.